ARTICLE | Company News
CeNeS, Tripos deal
September 18, 2006 7:00 AM UTC
The companies extended to 2007 a 2003 deal to jointly develop catechol-O-methyltransferase ( COMT) inhibitors to treat Parkinson’s disease (PD). The COMT inhibitors are in lead optimization. ...